Status:
COMPLETED
Steno Diabetes Dialogue Cards Teaching on Group Education on Blood Sugar Control in Adolescents With Type 1 Diabetes
Lead Sponsor:
National Taipei University of Nursing and Health Sciences
Conditions:
Type 1 Diabetes
HbA1c
Eligibility:
All Genders
10-18 years
Phase:
NA
Brief Summary
The Type 1 diabetes is the autoimmunity system produces the antibody which starts to attack the B lymphocytes while the autoimmunity is also been attacked. When the autoimmunity system has been destoy...
Eligibility Criteria
Inclusion
- 10-18years ord Type 1 DM.
- Able to read and write Chinese.
Exclusion
- Communication and cognitive impairments.
Key Trial Info
Start Date :
October 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 12 2021
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT05394532
Start Date
October 2 2020
End Date
December 12 2021
Last Update
June 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fangyi Lin
Taipei, Beitou, Taiwan, 112303